Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LSD microdosing versus active placebo for major depressive disorder
ACTRN12624000128594Phase 2Completed
- Sponsor
- The University of Auckland
- Start
- Mar 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of Lysergide, sponsored by The University of Auckland. Started Mar 2024; status: completed.
02
Drugs
Lysergide
Beyond the preview
Go deeper on ACTRN12624000128594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12624000128594.